Waystar Holding Corp. (WAY) Stock Price & Analysis

Waystar Holding Corp. (WAY) closed at USD 28.92 on Wednesday, October 28, 2026, up 3.21% on the day. The US market is currently closed; this is not a live price.

The prior close was USD 28.02; the Oct 28, 2026 session ranged USD 27.58–28.93 on volume of 1,446,965 shares. Market capitalization is $5.55B, with a 52-week range of USD 17.26–40.35 (NMS). Source: Nexqual, retrieved October 29, 2026 at 05:35 UTC.

Also available as compact Markdown for AI agents: nexqual.com/WAY.md

Key facts (WAY)

• Last four reported quarters (through Jun 30, 2026): revenue $1.21B, net income $135M (11.2% margin), free cash flow $246M (SEC filings).
• Valuation: P/E 41.1x (avg 54.0x at the last 1 fiscal year-ends), EV/EBITDA 15.8x, net debt $1.28B.
• Insider open-market sales, last ~7 months: 4 Form 4 filings, $8.0M; 0 not under a Rule 10b5-1 plan ($0K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
• Analysts: Buy (mean 1.91 on a 1–5 scale) (23 analysts), mean target USD 34.09 (range 28–44).
• Total return with dividends: 1Y -27.0% vs S&P 500 +13.6%; 5Y +39.7% vs S&P 500 +79.8%.
• Next earnings: 2026-11-02, EPS estimate USD 0.41, revenue estimate $323M.

Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (WAY)

Fiscal years end Dec. EPS is split-adjusted.

Valuation (price ÷ last four quarters, through Jun 30, 2026) (WAY)

P/E 41.1x · P/S 4.6x · EV/EBITDA 15.8x · EV/Sales 5.7x · P/FCF 22.5x · P/B 1.4x · FCF yield 4.44% · Earnings yield 2.43% · Net debt $1.28B · EV $6.82B

P/E at fiscal year-ends: Dec 2025 54.0x.

Insider sales (SEC Form 4, open-market, last ~7 months) (WAY)

4 of 4 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.

% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).

Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

Analysts (WAY)

Consensus Buy (mean 1.91 on a 1–5 scale), 23 analysts; mean target USD 34.09 (low 28, high 44).

Rating changes, last 120 days:

Total return (dividends reinvested) (WAY)

WAY earnings history and stock reaction

EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).

WAY recent SEC filings (last 120 days)

Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.

WAY revenue by product line (quarter ended Jun 30, 2026)

As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).

WAY suppliers, customers and competitors (named in its 10-K)

Quoted from the company's 10-K filed Feb 17, 2026.

WAY analyst estimates and revisions

WAY options: expected move

Options price a move of about ±13.1% (±$3.75) by Nov 20, 2026, which includes earnings on Nov 2, 2026. Over the last 8 reports the stock moved ±7.6% on average.

30-day implied volatility 48.5% vs 39.3% realized over the last 30 trading days. Put/call ratio (volume) 0. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.

Key Statistics (as of October 29, 2026 at 05:35 UTC)

Technical Analysis (WAY)

Nexqual's technical model rates WAY "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 29, 2026 at 05:35 UTC.

Analyst Ratings (WAY)

Wall Street analysts rate WAY "Buy" based on 23 analysts, with a mean price target of USD 34.09 (range USD 28–44), per Nexqual as of October 29, 2026 at 05:35 UTC.

Earnings (WAY)

Recent Earnings History

Source: Nexqual, October 29, 2026 at 05:35 UTC.

Financials & Fundamentals (WAY)

Source: Nexqual, October 29, 2026 at 05:35 UTC.

Financial Health Score (WAY)

Nexqual rates Waystar Holding Corp.'s overall financial health "Solid" across five dimensions, as of October 29, 2026 at 05:35 UTC.

Ownership (WAY)

Source: Nexqual, October 29, 2026 at 05:35 UTC.

Leadership (WAY)

Waystar Holding Corp. is led by Matthew J. Hawkins, CEO & Director, per Nexqual as of October 29, 2026 at 05:35 UTC.

Major Backers & Investors (WAY)

Notable institutional backers of Waystar Holding Corp. include Eqt Fund Management S.a R.l., Canada Pension Plan Investment Board, FMR, LLC, according to Nexqual as of October 29, 2026 at 05:35 UTC.

Active Investors

Index Funds (Passive)

Source: Nexqual, October 29, 2026 at 05:35 UTC.

From Waystar Holding Corp.'s Latest SEC 10-K Filing (filed 2026-02-17)

Key Strengths & Strategy (as disclosed to the SEC)

• Our platform enables us to provide industry-leading technology at scale to over 30,000 clients and processes over 7.5 billion healthcare payment transactions, representing more than $2.4 trillion in annual gross claims.
• Our Waystar AltitudeAI capabilities utilizes a multi-modal approach - incorporating machine learning, large language models such as Google Cloud's Gemini, generative AI, and agentic AI - to ensure our technology is built to act rather than just analyze.
• We have cultivated a company culture that is focused on helping our clients by developing and delivering industry-leading software solutions.
• We have infrastructure in place with co-located data centers, and within Microsoft Azure, Amazon Web Services, and Google Cloud Platform environments, to securely manage and maintain our clients' patient information.

Legal & Regulatory Risks (Item 1A, quoted)

• Our AI platform and the data it uses may also subject us to additional risks.
• We are also subject to self-regulatory standards and industry certifications that may legally or contractually apply to us.
• The healthcare industry is rapidly evolving, and we may experience reduced revenues and/or be forced to reduce our prices in response to changes to the healthcare regulatory landscape.
• We may be a party to legal, regulatory, and other proceedings that could result in adverse outcomes.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 29, 2026 at 05:35 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt